Robust systemic transduction with AAV9 vectors in mice: efficient global cardiac gene transfer superior to that of AAV8
Open accessAbstract
It has been recently shown that recombinant adeno-associated virus serotype 8 (rAAV8) is a robust alternative serotype vector that overcomes many of the limitations of rAAV2 and transduces various tissues efficiently and globally through systemic vector administration. AAV9 is a serotype newly isolated from human tissues, but our knowledge of the biology of rAAV9 in vivo is currently limited. Here, we demonstrate by a series of comprehensive side-by-side experiments with rAAV8 and 9 vectors delivered via different routes or at various doses in mice that rAAV9 vectors share the robustness of rAAV8, i.e., (1) very high liver transduction efficiency irrespective of whether vectors are administered intravascularly or extravascularly and (2) substantial transduction in the heart, skeletal muscle, and pancreas by peripheral vein injection. Importantly, rAAV9 transduced myocardium 5- to 10-fold higher than rAAV8, resulting in over 80% cardiomyocyte transduction following tail vein injection of as low as 1.0 x 10(11) particles per mouse. Thus rAAV9, as well as rAAV8, is a robust vector for gene therapy applications and rAAV9 is superior to rAAV8 specifically for cardiac gene delivery by systemic vector administration.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
AAV9 capsid and EF1a promoter ensure maximal distribution to most tissues.
“We selected AAV9 capsid and EF1a promoter to ensure maximal distribution to most tissues (Inagaki et al., 2006 and Supplementary Table S1)”
From Gene Therapy-Mediated Partial Reprogramming Extends Lifespan and Reverses Age-Related Changes in Aged Mice (2024) · cites this paper as Inagaki et al., 2006
AAV9 was chosen for its ability to highly transduce most mouse tissues.
“AAV9 was chosen for its ability to highly transduce most mouse tissues.25”
From Adeno-Associated Virus Serotype-Specific Inverted Terminal Repeat Sequence Role in Vector Transgene Expression (2020) · cites this paper as [25]
AAV-9 has superior cardiotropism than other serotypes in small rodents.
“AAV-9 has been shown to have superior cardiotropism than other serotypes in small rodents”
From Small and large animal models in cardiac contraction research: advantages and disadvantages (2014) · cites this paper as Inagaki, et al., 2006
Cites
Novel adeno-associated viruses from rhesus monkeys as vectors for human gene therapy
Gao, G.-P., Alvira, M. R., Wang, L., Calcedo, R., Johnston, J., & Wilson, J. M. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.182412299 · Cited by 1,520 · see citing works
Clades of Adeno-Associated Viruses Are Widely Disseminated in Human Tissues
Gao, G., Vandenberghe, L. H., Alvira, M. R., Lu, Y., Calcedo, R., Zhou, X., & Wilson, J. M. (2004) · Journal of Virology · doi:10.1128/jvi.78.12.6381-6388.2004 · Cited by 1,070 · see citing works
Systemic delivery of genes to striated muscles using adeno-associated viral vectors
Gregorevic, P., Blankinship, M. J., Allen, J. M., Crawford, R. W., Meuse, L., Miller, D. G., Russell, D. W., & Chamberlain, J. S. (2004) · Nature Medicine · doi:10.1038/nm1085 · Cited by 620 · see citing works
Adeno-associated virus serotype 8 efficiently delivers genes to muscle and heart
Wang, Z., Zhu, T., Qiao, C., Zhou, L., Wang, B., Zhang, J., Chen, C., Li, J., & Xiao, X. (2005) · Nature Biotechnology · doi:10.1038/nbt1073 · Cited by 602 · see citing works
Gene therapy vectors based on adeno-associated virus type 1
Xiao, W., Chirmule, N., Berta, S. C., McCullough, B., Gao, G., & Wilson, J. M. (1999) · Journal of Virology · doi:10.1128/jvi.73.5.3994-4003.1999 · Cited by 541 · see citing works
Duan, D., Sharma, P., Yang, J., Yue, Y., Dudus, L., Zhang, Y., Fisher, K. J., & Engelhardt, J. F. (1998) · Journal of Virology · doi:10.1128/jvi.72.11.8568-8577.1998 · Cited by 522 · see citing works
Nakai, H., Yant, S. R., Storm, T. A., Fuess, S., Meuse, L., & Kay, M. A. (2001) · Journal of Virology · doi:10.1128/jvi.75.15.6969-6976.2001 · Cited by 478 · see citing works
Self-citationRutledge, E. A., Halbert, C. L., & Russell, D. W. (1998) · Journal of Virology · doi:10.1128/jvi.72.1.309-319.1998 · Cited by 452 · see citing works
Cearley, C. N., & Wolfe, J. H. (2006) · Molecular Therapy · doi:10.1016/j.ymthe.2005.11.015 · Cited by 409 · see citing works
Grimm, D., & Kay, M. A. (2003) · Current Gene Therapy · doi:10.2174/1566523034578285 · Cited by 349 · see citing works
Self-citationCloning and Characterization of Adeno-Associated Virus Type 5
Chiorini, J. A., Kim, F., Yang, L. C., & Kotin, R. M. (1999) · Journal of Virology · doi:10.1128/jvi.73.2.1309-1319.1999 · Cited by 332 · see citing works
Unrestricted Hepatocyte Transduction with Adeno-Associated Virus Serotype 8 Vectors in Mice
Nakai, H., Fuess, S., Storm, T. A., Muramatsu, S., Nara, Y., & Kay, M. A. (2004) · Journal of Virology · doi:10.1128/jvi.79.1.214-224.2005 · Cited by 322 · see citing works
Self-citationEfficient transduction of skeletal muscle using vectors based on adeno-associated virus serotype 6
Blankinship, M. J., Gregorevic, P., Allen, J. M., Harper, S. Q., Harper, H. A., Halbert, C. L., Miller, A. D., & Chamberlain, J. S. (2004) · Molecular Therapy · doi:10.1016/j.ymthe.2004.07.016 · Cited by 250 · see citing works
Cloning of adeno-associated virus type 4 (AAV4) and generation of recombinant AAV4 particles
Chiorini, J. A., Yang, L., Liu, Y., Safer, B., & Kotin, R. M. (1997) · Journal of Virology · doi:10.1128/jvi.71.9.6823-6833.1997 · Cited by 231 · see citing works
Preclinical in vivo evaluation of pseudotyped adeno-associated virus vectors for liver gene therapy
Grimm, D., Zhou, S., Nakai, H., Thomas, C. E., Storm, T. A., Fuess, S., Matsushita, T., Allen, J. M., Surosky, R. T., Lochrie, M. A., et al. (2003) · Blood · doi:10.1182/blood-2003-02-0495 · Cited by 208 · see citing works
Self-citationTotal correction of hemophilia A mice with canine FVIII using an AAV 8 serotype
Sarkar, R., Tetreault, R., Gao, G., Wang, L., Bell, P. L., Chandler, R. J., Wilson, J. M., & Kazazian, H. H. (2003) · Blood · doi:10.1182/blood-2003-08-2954 · Cited by 201 · see citing works
Isolation of Recombinant Adeno-Associated Virus Vector-Cellular DNA Junctions from Mouse Liver
Nakai, H., Iwaki, Y., Kay, M. A., & Couto, L. B. (1999) · Journal of Virology · doi:10.1128/jvi.73.7.5438-5447.1999 · Cited by 186 · see citing works
Self-citationNucleotide Sequencing and Generation of an Infectious Clone of Adeno-Associated Virus 3
Muramatsu, S., Mizukami, H., Young, N. S., & Brown, K. E. (1996) · Virology · doi:10.1006/viro.1996.0367 · Cited by 159 · see citing works
Song, S., Embury, J. E., Laipis, P., Berns, K., Crawford, J., & Flotte, T. R. (2001) · Gene Therapy · doi:10.1038/sj.gt.3301422 · Cited by 152 · see citing works
De, B. P., Heguy, A., Hackett, N. R., Ferris, B., Leopold, P. L., Lee, J., Pierre, L., Gao, G., Wilson, J. M., & Crystal, R. G. (2006) · Molecular Therapy · doi:10.1016/j.ymthe.2005.09.003 · Cited by 129 · see citing works
Nakai, H., Thomas, C. E., Storm, T. A., Fuess, S., Powell, S. K., Wright, J. F., & Kay, M. A. (2002) · Journal of Virology · doi:10.1128/jvi.76.22.11343-11349.2002 · Cited by 99 · see citing works
Self-citationZhu, T., Zhou, L., Mori, S., Wang, Z., McTiernan, C. F., Qiao, C., Chen, C., Wang, D. W., Li, J., & Xiao, X. (2005) · Circulation · doi:10.1161/circulationaha.105.565598 · Cited by 94 · see citing works
Self-citationCustom Adeno-Associated Virus Capsids: The Next Generation of Recombinant Vectors with Novel Tropism
Muzyczka, N., & Warrington, K. H. (2005) · Human Gene Therapy · doi:10.1089/hum.2005.16.408 · Cited by 80 · see citing works
Transduction of Renal Cells in Vitro and in Vivo by Adeno-Associated Virus Gene Therapy Vectors
Lipkowitz, M. S., Hanss, B. G., Tulchin, N., Wilson, P. D., Langer, J., ROSS, M. D., Kurtzman, G. J., Klotman, P. E., & Klotman, M. E. (1999) · Journal of the American Society of Nephrology · doi:10.1681/asn.v1091908 · Cited by 64 · see citing works
Comparison of gene expression after intraperitoneal delivery of AAV2 or AAV5 in utero
Lipshutz, G. S., Titre, D., Brindle, M. E., Bisconte, A. R., Contag, C. H., & Gaensler, K. M. L. (2003) · Molecular Therapy · doi:10.1016/s1525-0016(03)00132-1 · Cited by 37 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
Chan, K. Y., Jang, M. J., Yoo, B. B., Greenbaum, A., Ravi, N., Wu, W.-L., Sánchez-Guardado, L., Lois, C., Mazmanian, S. K., Deverman, B. E., et al. (2017) · Nature Neuroscience · doi:10.1038/nn.4593 · Cited by 1,578 · see citing works
Analysis of AAV Serotypes 1–9 Mediated Gene Expression and Tropism in Mice After Systemic Injection
Zincarelli, C., Soltys, S., Rengo, G., & Rabinowitz, J. E. (2008) · Molecular Therapy · doi:10.1038/mt.2008.76 · Cited by 1,490 · see citing works
Intravascular AAV9 preferentially targets neonatal neurons and adult astrocytes
Foust, K. D., Nurre, E., Montgomery, C. L., Hernandez, A., Chan, C. M., & Kaspar, B. K. (2009) · Nature Biotechnology · doi:10.1038/nbt.1515 · Cited by 1,456 · see citing works
Functional screening identifies miRNAs inducing cardiac regeneration
Eulalio, A., Mano, M., Ferro, M. D., Zentilin, L., Sinagra, G., Zacchigna, S., & Giacca, M. (2012) · Nature · doi:10.1038/nature11739 · Cited by 1,029 · see citing works
Therapeutic in vivo gene transfer for genetic disease using AAV: Progress and challenges
Mingozzi, F., & High, K. A. (2011) · Nature Reviews Genetics · doi:10.1038/nrg2988 · Cited by 893 · see citing works
Jessup, M., Greenberg, B., Mancini, D., Cappola, T., Pauly, D. F., Jaski, B., Yaroshinsky, A., Zsebo, K. M., Dittrich, H., & Hajjar, R. J. (2011) · Circulation · doi:10.1161/circulationaha.111.022889 · Cited by 760 · see citing works
Grimm, D., Lee, J. S., Wang, L., Desai, T., Akache, B., Storm, T. A., & Kay, M. A. (2008) · Journal of Virology · doi:10.1128/jvi.00254-08 · Cited by 696 · see citing works
Self-citationConsensus guidelines for the use and interpretation of angiogenesis assays
Nowak-Sliwinska, P. M., Alitalo, K. K., Allen, E., Anisimov, A., Aplin, A. C., Auerbach, R., Augustin, H. G., Bates, D. O., B, J. R. V. B., Bender, R. H. F., et al. (2018) · Angiogenesis · doi:10.1007/s10456-018-9613-x · Cited by 600 · see citing works
Bernardes de Jesus, B., Vera, E., Schneeberger, K., Tejera, A. M., Ayuso, E., Bosch, F., & Blasco, M. A. (2012) · EMBO Molecular Medicine · doi:10.1002/emmm.201200245 · Cited by 548 · see citing works
Ackers-Johnson, M. A., Li, P. Y., Holmes, A. P., O’Brien, S.-M., Pavlović, D., & Foo, R. (2016) · Circulation Research · doi:10.1161/circresaha.116.309202 · Cited by 548 · see citing works
Aschauer, D. F., Kreuz, S., & Rumpel, S. (2013) · PLoS ONE · doi:10.1371/journal.pone.0076310 · Cited by 522 · see citing works
Duque, S., Joussemet, B., Riviere, C., Marais, T., Dubreil, L., Douar, A.-M., Fyfe, J., Moullier, P., Colle, M.-A., & Barkats, M. (2009) · Molecular Therapy · doi:10.1038/mt.2009.71 · Cited by 511 · see citing works
In vivo base editing rescues Hutchinson–Gilford progeria syndrome in mice
Koblan, L. W., Erdos, M. R., Wilson, C., Cabral, W. A., Levy, J. M., Xiong, Z., Tavarez, U. L., Davison, L. M., Gete, Y. G., Mao, X., et al. (2021) · Nature · doi:10.1038/s41586-020-03086-7 · Cited by 479 · see citing works
Small and large animal models in cardiac contraction research: advantages and disadvantages
Milani-Nejad, N., & Janssen, P. M. L. (2014) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2013.10.007 · Cited by 484 · see citing works
Levy, J. M., Yeh, W.-H., Pendse, N. D., Davis, J. R., Hennessey, E., Butcher, R. M., Koblan, L. W., Comander, J., Liu, Q., & Liu, D. R. (2020) · Nature Biomedical Engineering · doi:10.1038/s41551-019-0501-5 · Cited by 472 · see citing works
Non-coding RNAs in cardiovascular diseases: diagnostic and therapeutic perspectives
Poller, W. C., Dimmeler, S., Heymans, S. R. B., Zeller, T., Haas, J., Karakas, M., Leistner, D. M., Jakob, P., Nakagawa, S., Blankenberg, S., et al. (2017) · European Heart Journal · doi:10.1093/eurheartj/ehx165 · Cited by 412 · see citing works
Keeler, A. M., & Flotte, T. R. (2019) · Annual Review of Virology · doi:10.1146/annurev-virology-092818-015530 · Cited by 322 · see citing works
Various AAV Serotypes and Their Applications in Gene Therapy: An Overview
Issa, S. S., Shaimardanova, A. A., Solovyeva, V. V., & Rizvanov, A. A. (2023) · Cells · doi:10.3390/cells12050785 · Cited by 319 · see citing works
Bish, L. T., Morine, K., Sleeper, M. M., Sanmiguel, J. C., Wu, D., Gao, G., Wilson, J. M., & Sweeney, H. L. (2008) · Human Gene Therapy · doi:10.1089/hum.2008.123 · Cited by 291 · see citing works
The role of hepatokines in NAFLD
Stefan, N., Schick, F., Birkenfeld, A. L., Häring, H., & White, M. F. (2023) · Cell Metabolism · doi:10.1016/j.cmet.2023.01.006 · Cited by 282 · see citing works
Asokan, A., Conway, J. C., Phillips, J. L., Li, C., Hegge, J., Sinnott, R., Yadav, S. S., DiPrimio, N., Nam, H. J., Agbandje‐McKenna, M., et al. (2009) · Nature Biotechnology · doi:10.1038/nbt.1599 · Cited by 265 · see citing works
Roux-Buisson, N., Cacheux, M., Fourest‐Lieuvin, A., Fauconnier, J., Brocard, J., Denjoy, I., Durand, P., Guicheney, P., Kyndt, F., Leenhardt, A., et al. (2012) · Human Molecular Genetics · doi:10.1093/hmg/dds104 · Cited by 262 · see citing works
Virus-mediated gene delivery for human gene therapy
Giacca, M., & Zacchigna, S. (2012) · Journal of Controlled Release · doi:10.1016/j.jconrel.2012.04.008 · Cited by 302 · see citing works
Intracellular transport of recombinant adeno-associated virus vectors
Nonnenmacher, M., & Weber, T. (2012) · Gene Therapy · doi:10.1038/gt.2012.6 · Cited by 258 · see citing works
Prasad, K.-M. R., Xu, Y., Yang, Z., Acton, S. T., & French, B. A. (2010) · Gene Therapy · doi:10.1038/gt.2010.105 · Cited by 249 · see citing works
Salva, M. Z., Himeda, C. L., Tai, P. W., Nishiuchi, E., Gregorevic, P., Allen, J. M., Finn, E. E., Nguyen, Q. G., Blankinship, M. J., Meuse, L., et al. (2007) · Molecular Therapy · doi:10.1038/sj.mt.6300027 · Cited by 232 · see citing works
Whole body correction of mucopolysaccharidosis IIIA by intracerebrospinal fluid gene therapy
Haurigot, V., Marcó, S., Ribera, A., Garcia, M., Ruzo, A., Villacampa, P., Ayuso, E., Añor, S., Andaluz, A., Pineda, M., et al. (2013) · Journal of Clinical Investigation · doi:10.1172/jci66778 · Cited by 215 · see citing works
Structural insight into the unique properties of adeno-associated virus serotype 9
DiMattia, M. A., Nam, H.-J., Van Vliet, K., Mitchell, M., Bennett, A., Gurda, B. L., McKenna, R., Olson, N. H., Sinkovits, R. S., Potter, M., et al. (2012) · Journal of Virology · doi:10.1128/jvi.07232-11 · Cited by 219 · see citing works
Basic Biology of Adeno-Associated Virus (AAV) Vectors Used in Gene Therapy
Balakrishnan, B., & Jayandharan, G. (2014) · Current Gene Therapy · doi:10.2174/1566523214666140302193709 · Cited by 225 · see citing works
Engineering Liver-detargeted AAV9 Vectors for Cardiac and Musculoskeletal Gene Transfer
Pulicherla, N., Shen, S., Yadav, S. S., Debbink, K. M., Lakshmanan Govindasamy, A., Agbandje‐McKenna, M., & Asokan, A. (2011) · Molecular Therapy · doi:10.1038/mt.2011.22 · Cited by 223 · see citing works
Wang, Z., Kuhr, C. S., Allen, J. M., Blankinship, M. J., Gregorevic, P., Chamberlain, J. S., Tapscott, S. J., & Storb, R. F. (2007) · Molecular Therapy · doi:10.1038/sj.mt.6300161 · Cited by 218 · see citing works
miR-26a is required for skeletal muscle differentiation and regeneration in micePreprint
Dey, B. K., Gagan, J., Yan, Z., & Dutta, A. (2012) · Genes & Development · doi:10.1101/gad.198085.112 · Cited by 218 · see citing works
Optogenetics for in vivo cardiac pacing and resynchronization therapies
Nussinovitch, U., & Gepstein, L. (2015) · Nature Biotechnology · doi:10.1038/nbt.3268 · Cited by 216 · see citing works
Endoplasmic reticulum stress in the heart: insights into mechanisms and drug targets
Wang, X., Binder, P., Fang, Q., Wang, Z., Xiao, W. L., Liu, W., & Wang, X. (2017) · British Journal of Pharmacology · doi:10.1111/bph.13888 · Cited by 216 · see citing works
Recombinant Adeno-associated Virus Transduction and Integration
Schultz, B. R., & Chamberlain, J. S. (2008) · Molecular Therapy · doi:10.1038/mt.2008.103 · Cited by 216 · see citing works
Suckau, L., Fechner, H., Chemaly, E. R., Krohn, S., Hadri, L., Kockskämper, J., Westermann, D., Bisping, E. H., Ly, H. Q., Wang, X., et al. (2009) · Circulation · doi:10.1161/circulationaha.108.783852 · Cited by 211 · see citing works
A myocardium tropic adeno-associated virus (AAV) evolved by DNA shuffling and in vivo selection
Yang, L., Jiang, J., Drouin, L. M., Agbandje‐McKenna, M., Chen, C., Qiao, C., Pu, D., Hu, X., Wang, D.-Z., Li, J., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0813207106 · Cited by 208 · see citing works
Zhang, Y., Jiao, L., Sun, L., Li, Y., Gao, Y., Xu, C., Shao, Y., Li, C., Li, C., Lu, Y., et al. (2018) · Circulation Research · doi:10.1161/circresaha.117.312117 · Cited by 209 · see citing works
Li, H., Fan, J., Zhao, Y., Zhang, X., Dai, B., Zhan, J., Yin, Z., Nie, X., Fu, X., Chen, C., et al. (2019) · Circulation Research · doi:10.1161/circresaha.119.314898 · Cited by 207 · see citing works
Monteilhet, V., Saheb, S., Boutin, S., Leborgne, C., Veron, P., Montus, M.-F., Moullier, P., Benveniste, O., & Masurier, C. (2011) · Molecular Therapy · doi:10.1038/mt.2011.108 · Cited by 206 · see citing works
Klein, R. L., Dayton, R. D., Tatom, J. B., Henderson, K. M., & Henning, P. P. (2008) · Molecular Therapy · doi:10.1038/sj.mt.6300331 · Cited by 196 · see citing works
Davis, J. R., Wang, X., Witte, I. P., Huang, T. P., Levy, J. M., Raguram, A., Banskota, S., Seidah, N. G., Musunuru, K., & Liu, D. R. (2022) · Nature Biomedical Engineering · doi:10.1038/s41551-022-00911-4 · Cited by 195 · see citing works
Sarcoplasmic reticulum Ca2+ATPase as a therapeutic target for heart failure
Lipskaia, L., Chemaly, E. R., Hadri, L., Lompré, A., & Hajjar, R. J. (2009) · Expert Opinion on Biological Therapy · doi:10.1517/14712590903321462 · Cited by 193 · see citing works
The AAV9 receptor and its modification to improve in vivo lung gene transfer in mice
Bell, C. L., Vandenberghe, L. H., Bell, P., Limberis, M. P., Gao, G.-P., Van Vliet, K., Agbandje-McKenna, M., & Wilson, J. M. (2011) · Journal of Clinical Investigation · doi:10.1172/jci57367 · Cited by 190 · see citing works
Recent developments in adeno‐associated virus vector technology
Büning, H., Perabò, L., Coutelle, O., Quadt‐Humme, S., & Hallek, M. J. (2008) · The Journal of Gene Medicine · doi:10.1002/jgm.1205 · Cited by 189 · see citing works
Byrne, M. J., Power, J. M., Preovolos, A., Mariani, J. A., Hajjar, R. J., & Kaye, D. M. (2008) · Gene Therapy · doi:10.1038/gt.2008.120 · Cited by 184 · see citing works
A mouse model for adult cardiac-specific gene deletion with CRISPR/Cas9
Carroll, K. J., Makarewich, C. A., McAnally, J., Anderson, D. M., Zentilin, L., Liu, N., Giacca, M., Bassel‐Duby, R., & Olson, E. N. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1523918113 · Cited by 185 · see citing works
DNA Shuffling of Adeno-associated Virus Yields Functionally Diverse Viral Progeny
Koerber, J. T., Jang, J.-H., & Schaffer, D. V. (2008) · Molecular Therapy · doi:10.1038/mt.2008.167 · Cited by 181 · see citing works
Bostick, B., Ghosh, A., Yue, Y., Long, C., & Duan, D. (2007) · Gene Therapy · doi:10.1038/sj.gt.3303029 · Cited by 180 · see citing works
Childers, M. K., Joubert, R., Poulard, K., Moal, C., Grange, R. W., Doering, J. A., Lawlor, M. W., Rider, B. E., Jamet, T., Danièle, N., et al. (2014) · Science Translational Medicine · doi:10.1126/scitranslmed.3007523 · Cited by 173 · see citing works
Yue, Y., Ghosh, A., Long, C., Bostick, B., Smith, B. F., Kornegay, J. N., & Duan, D. (2008) · Molecular Therapy · doi:10.1038/mt.2008.207 · Cited by 173 · see citing works
Rincón, M. Y., VandenDriessche, T., & Chuah, M. (2015) · Cardiovascular Research · doi:10.1093/cvr/cvv205 · Cited by 168 · see citing works
Qiao, C., Yuan, Z., Li, J., He, B., Zheng, H., Mayer, C., Li, J., & Xiao, X. (2011) · Gene Therapy · doi:10.1038/gt.2010.157 · Cited by 163 · see citing works
Tailoring the AAV vector capsid for gene therapy
Vandenberghe, L. H., Wilson, J. M., & Gao, G. (2009) · Gene Therapy · doi:10.1038/gt.2008.170 · Cited by 155 · see citing works
Zhang, Y., Li, H. Z., Min, Y.-L., Sanchez‐Ortiz, E., Huang, J. H., Mireault, A. A., Shelton, J. M., Kim, J., Mammen, P. P. A., Bassel‐Duby, R., et al. (2020) · Science Advances · doi:10.1126/sciadv.aay6812 · Cited by 160 · see citing works
Therapeutic approaches for muscle wasting disorders
Lynch, G. S., Schertzer, J. D., & Ryall, J. G. (2006) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2006.11.004 · Cited by 152 · see citing works
Vandenberghe, L. H., Xiao, R., Lock, M., Lin, J., Korn, M., & Wilson, J. M. (2010) · Human Gene Therapy · doi:10.1089/hum.2010.107 · Cited by 151 · see citing works
Adachi, K., Enoki, T., Kawano, Y., Veraz, M., & Nakai, H. (2014) · Nature Communications · doi:10.1038/ncomms4075 · Cited by 149 · see citing works
Self-citationVersatility of AAV vectors for retinal gene transfer
Surace, E. M., & Auricchio, A. (2007) · Vision Research · doi:10.1016/j.visres.2007.07.027 · Cited by 145 · see citing works
The advent of AAV9 expands applications for brain and spinal cord gene delivery
Dayton, R. D., Wang, D. B., & Klein, R. L. (2012) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.2012.681463 · Cited by 144 · see citing works
Varadi, K., Michelfelder, S., Korff, T., Hecker, M., Trepel, M., Katus, H. A., Kleinschmidt, J. A., & Müller, O. J. (2011) · Gene Therapy · doi:10.1038/gt.2011.143 · Cited by 145 · see citing works
Gene Therapy for Heart Failure
Tilemann, L. M., Ishikawa, K., Weber, T., & Hajjar, R. J. (2012) · Circulation Research · doi:10.1161/circresaha.111.252981 · Cited by 140 · see citing works
Adeno-Associated Virus Vectors as Therapeutic and Investigational Tools in the Cardiovascular System
Zacchigna, S., Zentilin, L., & Giacca, M. (2014) · Circulation Research · doi:10.1161/circresaha.114.302331 · Cited by 140 · see citing works
Natkunarajah, M., Trittibach, P., McIntosh, J., Duran, Y., Barker, S. E., Smith, A. J., Nathwani, A. C., & Ali, R. R. (2008) · Gene Therapy · doi:10.1038/sj.gt.3303074 · Cited by 138 · see citing works
Identification of the Galactose Binding Domain of the Adeno-Associated Virus Serotype 9 Capsid
Bell, C. L., Gurda, B. L., Vliet, K. V., Agbandje‐McKenna, M., & Wilson, J. M. (2012) · Journal of Virology · doi:10.1128/jvi.00448-12 · Cited by 138 · see citing works
Zincarelli, C., Soltys, S., Rengo, G., Koch, W. J., & Rabinowitz, J. E. (2010) · Clinical and Translational Science · doi:10.1111/j.1752-8062.2010.00190.x · Cited by 137 · see citing works
Adeno-Associated Viral Vectors and Their Redirection to Cell-Type Specific Receptors
Michelfelder, S., & Trepel, M. (2009) · Advances in genetics · doi:10.1016/s0065-2660(09)67002-4 · Cited by 134 · see citing works
AAV-Mediated Liver-Directed Gene Therapy
Sands, M. S. (2011) · Methods in molecular biology · doi:10.1007/978-1-61779-370-7_6 · Cited by 134 · see citing works
Lu, Q., Ma, Z., Ye, D., Bédarida, T., Chen, L., Xie, Z., Song, P., & Zou, M. (2019) · Nature Communications · doi:10.1038/s41467-019-10116-0 · Cited by 136 · see citing works
Geisler, A., Jungmann, A., Kurreck, J., Poller, W. C., Katus, H. A., Vetter, R., Fechner, H., & Müller, O. J. (2010) · Gene Therapy · doi:10.1038/gt.2010.141 · Cited by 132 · see citing works
Katare, R., Caporali, A., Zentilin, L., Avolio, E., Sala‐Newby, G. B., Oikawa, A., Cesselli, D., Beltrami, A. P., Giacca, M., Emanueli, C., et al. (2011) · Circulation Research · doi:10.1161/circresaha.110.239111 · Cited by 130 · see citing works
Genome editing with CRISPR/Cas9 in postnatal mice corrects PRKAG2 cardiac syndrome
Xie, C., Zhang, Y., Song, L., Luo, J., Qi, W., Hu, J., Lu, D., Yang, Z. H., Zhang, J., Xiao, J., et al. (2016) · Cell Research · doi:10.1038/cr.2016.101 · Cited by 125 · see citing works
Foster, H., Sharp, P. S., Athanasopoulos, T., Trollet, C., Graham, I. R., Foster, K., Wells, D. J., & Dickson, G. (2008) · Molecular Therapy · doi:10.1038/mt.2008.186 · Cited by 119 · see citing works
CRISPR Modeling and Correction of Cardiovascular Disease
Liu, N., & Olson, E. N. (2022) · Circulation Research · doi:10.1161/circresaha.122.320496 · Cited by 118 · see citing works
Bär, C., Povedano, J. M., Serrano, R., Benitez-Buelga, C., Popkes, M., Formentini, I., Bobadilla, M., Bosch, F., & Blasco, M. A. (2016) · Blood · doi:10.1182/blood-2015-08-667485 · Cited by 116 · see citing works
Earley, L. F., Conatser, L. M., Lue, V. M., Dobbins, A. L., Li, C., Hirsch, M. L., & Samulski, R. J. (2020) · Human Gene Therapy · doi:10.1089/hum.2019.274 · Cited by 116 · see citing works
MiR-30c/PGC-1β protects against diabetic cardiomyopathy via PPARα
Yin, Z., Zhao, Y., He, M., Li, H., Fan, J., Nie, X., Yan, M., Chen, C., & Wang, D. W. (2019) · Cardiovascular Diabetology · doi:10.1186/s12933-019-0811-7 · Cited by 116 · see citing works
Adeno-associated viral vectors do not efficiently target muscle satellite cells
Arnett, A. L. H., Konieczny, P., Ramos, J. N., Hall, J. K., Odom, G., Yablonka‐Reuveni, Z., Chamberlain, J. R., & Chamberlain, J. S. (2014) · Molecular Therapy — Methods & Clinical Development · doi:10.1038/mtm.2014.38 · Cited by 110 · see citing works
Efficient precise in vivo base editing in adult dystrophic mice
Xu, L. M., Zhang, C., Bailin, P. L., Wang, P., Gao, Y., Mohler, P. J., Mokadam, N. A., Ma, J., Arnold, W. D., & Han, R. (2021) · Nature Communications · doi:10.1038/s41467-021-23996-y · Cited by 109 · see citing works
Pacak, C. A., Sakai, Y., Thattaliyath, B. D., Mah, C. S., & Byrne, B. J. (2008) · Genetic Vaccines and Therapy · doi:10.1186/1479-0556-6-13 · Cited by 111 · see citing works
Yuasa, K., Yoshimura, M., Urasawa, N., Ohshima, S., Howell, J. M., Nakamura, A., Hijikata, T., Miyagoe‐Suzuki, Y., & Takeda, S. (2007) · Gene Therapy · doi:10.1038/sj.gt.3302984 · Cited by 107 · see citing works
Messina, S., Mazzeo, A. T., Bitto, A., Aguennouz, M., Migliorato, A., Pasquale, M. G. D., Minutoli, L., Altavilla, D., Zentilin, L., Giacca, M., et al. (2007) · The FASEB Journal · doi:10.1096/fj.07-8459com · Cited by 107 · see citing works
Rubin, J. D., Nguyen, T. V., Allen, K. L., Ayasoufi, K., & Barry, M. A. (2019) · Human Gene Therapy · doi:10.1089/hum.2019.127 · Cited by 105 · see citing works
Shen, S., Horowitz, E. D., Troupes, A. N., Brown, S. M., Pulicherla, N., Samulski, R. J., Agbandje‐McKenna, M., & Asokan, A. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.482380 · Cited by 103 · see citing works
GJA1-20k Arranges Actin to Guide Cx43 Delivery to Cardiac Intercalated Discs
Basheer, W. A., Xiao, S., Epifantseva, I., Fu, Y., Kléber, A. G., Hong, T., & Shaw, R. M. (2017) · Circulation Research · doi:10.1161/circresaha.117.311955 · Cited by 104 · see citing works
Ruzo, A., Marcó, S., García, M., Villacampa, P., Ribera, A., Ayuso, E., Maggioni, L., Mingozzi, F., Haurigot, V., & Bosch, F. (2012) · Human Gene Therapy · doi:10.1089/hum.2012.029 · Cited by 104 · see citing works
Systemic delivery of adeno-associated viral vectors
Duan, D. (2016) · Current Opinion in Virology · doi:10.1016/j.coviro.2016.07.006 · Cited by 103 · see citing works
Rescue of cardiomyopathy through U7snRNA‐mediated exon skipping in Mybpc3‐targeted knock‐in mice
Gedicke, C., Behrens‐Gawlik, V., Reischmann, S., Geertz, B., Stimpel, D., Weinberger, F., Schlossarek, S., Précigout, G., Braren, I., Thomas Eschenhagen, A., et al. (2013) · EMBO Molecular Medicine · doi:10.1002/emmm.201202168 · Cited by 101 · see citing works
He, B., Tang, R., Weisleder, N. L., Xiao, B., Yuan, Z., Cai, C., Hua Zhu, C., Lin, P., Qiao, C., Li, J., et al. (2012) · Molecular Therapy · doi:10.1038/mt.2012.5 · Cited by 98 · see citing works
Pang, J.-J., Lauramore, A., Deng, W.-T., Li, Q., Doyle, T. J., Chiodo, V., Li, J., & Hauswirth, W. W. (2008) · Vision Research · doi:10.1016/j.visres.2007.08.009 · Cited by 97 · see citing works
AAV CRISPR editing rescues cardiac and muscle function for 18 months in dystrophic mice
Hakim, C. H., Wasala, N. B., Nelson, C. E., Wasala, L. P., Yue, Y., Louderman, J. A., Lessa, T. B., Dai, A., Zhang, K., Jenkins, G. J., et al. (2018) · JCI Insight · doi:10.1172/jci.insight.124297 · Cited by 99 · see citing works
Bostick, B., Yue, Y., Lai, Y., Long, C., Li, D., & Duan, D. (2008) · Human Gene Therapy · doi:10.1089/hum.2008.058 · Cited by 98 · see citing works
The potential of adeno-associated viral vectors for gene delivery to muscle tissue
Wang, D., Li, Z., Nahid, M. A., & Gao, G. (2014) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.2014.871258 · Cited by 97 · see citing works
Raake, P. W. J., Hinkel, R., Müller, S., Delker, S., Kreuzpointner, R., Kupatt, C., Katus, H. A., Kleinschmidt, J. A., Boekstegers, P., & Müller, O. J. (2007) · Gene Therapy · doi:10.1038/sj.gt.3303035 · Cited by 96 · see citing works
Macip, C. C., Hasan, R., Hoznek, V., Kim, J., Metzger, L. E., Sethna, S., & Davidsohn, N. (2023) · doi:10.1101/2023.01.04.522507 · Cited by 95 · see citing works
MicroRNA-regulated viral vectors for gene therapy
Geisler, A., & Fechner, H. (2016) · World Journal of Experimental Medicine · doi:10.5493/wjem.v6.i2.37 · Cited by 96 · see citing works
Werfel, S., Jungmann, A., Lehmann, L., Ksienzyk, J., Bekeredjian, R., Kaya, Z., Leuchs, B., Nordheim, A., Backs, J., Engelhardt, S. H., et al. (2014) · Cardiovascular Research · doi:10.1093/cvr/cvu174 · Cited by 94 · see citing works
Introducing Genes into Mammalian Cells: Viral VectorsPreprint
Sena‐Esteves, M., & Gao, G. (2020) · Cold Spring Harbor Protocols · doi:10.1101/pdb.top095513 · Cited by 89 · see citing works
Hadaczek, P., Forsayeth, J., Mirek, H., Munson, K., Bringas, J., Pivirotto, P., L McBride, J., Davidson, B. L., & Bankiewicz, K. S. (2009) · Human Gene Therapy · doi:10.1089/hum.2008.151 · Cited by 90 · see citing works
Structure of AAV-DJ, a Retargeted Gene Therapy Vector: Cryo-Electron Microscopy at 4.5 Å Resolution
Lerch, T. F., O’Donnell, J., Meyer, N., Xie, Q., Taylor, K. A., Stagg, S. M., & Chapman, M. S. (2012) · Structure · doi:10.1016/j.str.2012.05.004 · Cited by 89 · see citing works
- Authors
- Inagaki, K., Fuess, S., Storm, T. A., Gibson, G. A., Mctiernan, C. F., Kay, M. A., & Nakai, H.
- Affiliations
- University of Pittsburgh (US)
- Stanford Medicine (US)
- Corresponding author
- Nakai, Hiroyuki
- ORCID
- Venue
- Molecular Therapy
- Publisher
- Elsevier BV
- Published
- 2006-07
- Volume
- 14
- Issue
- 1
- Pages
- 45-53
- ISSN
- 1525-0016 (ISSN-L)
- OpenAlex
- W2065380345
- Cited by
- 610
- References
- 25
- Citations by year
- 2026: 26 · 2025: 19 · 2024: 21 · 2023: 18 · 2022: 25 · 2021: 24 · 2020: 27 · 2019: 38 · 2018: 29 · 2017: 24 · 2016: 33 · 2015: 30 · 2014: 25 · 2013: 39 · 2012: 45
- FWCI
- 21.39
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Molecular Therapy (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Funders
- National Heart, Lung, and Blood Institute (HL66948, U01HL066948)
- National Institute of Diabetes and Digestive and Kidney Diseases (R21DK068636, DK68636)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Virus-based gene therapy research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA Interference and Gene Delivery
- Health Sciences › Medicine › Genetics › Neurogenetic and Muscular Disorders Research
- Keywords
- AAV9, AAV8, adeno-associated virus vectors, systemic gene delivery, cardiac gene transfer, liver transduction, tail vein injection, skeletal muscle transduction, vector dose, gene therapy vectors
- MeSH terms
- Dependovirus, Animals, Female, Genetic Vectors, Lac Operon, Liver, Male, Mice, Inbred C57BL, Myocardium, Pancreas, Tissue Distribution, Genetic Therapy, Muscle, Skeletal, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review